![John Ketchum](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 459 116 $ in data 30/06/2026
John Ketchum is currently Chairman at Ernest Pharmaceuticals, Llc since 2022 and Independent Director at Tango Therapeutics, Inc. since 2023.
Formerly, Mr. Ketchum was Senior VP & Region Head-Emerging Growth Market at Novartis Oncology, Inc. from 2014 to 2017.
Education includes an undergraduate degree from Hamilton College (New York) and an MBA from The University of North Carolina at Chapel Hill.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 05/06/2026 | 14.687 ( 0,01% ) | 459 116 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| TANGO THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 29/08/2023 |
Ernest Pharmaceuticals, Lcc | Presidente | 01/12/2022 |
| Società | Posizione | Fine |
|---|---|---|
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Corporate Officer/Principal | 01/03/2017 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Hamilton College (New York)
 Hamilton College (New York) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Chapel Hill
 The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tango Therapeutics, Inc.
 Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | Health Technology |
Ernest Pharmaceuticals, Lcc |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
